Effect of glutathione-modulating compounds on platinum compounds-induced cytotoxicity in human glioma cell lines

Iida, M.; Doi, H.; Asamoto, S.; Sugiyama, H.; Sakagami, H.; Kuribayashi, N.; Takeda, M.; Okamura, Y.; Matsumoto, K.

Anticancer Research 19(6b): 5383-5384

1999


ISSN/ISBN: 0250-7005
PMID: 10697565
Document Number: 502487
The relation between the effect of glutathione(GSH)-modulating compounds and platinum compounds (Cisplatin, Nedaplatin)-induced cytotoxicity was investigated. Pretreatment of human glioblastoma (T98G, U87MG) and glioma (KG1C) cell lines with L-buthionine-[S,R]-sulfoximine, which decrease the intracellular GSH concentration, remarkably increased their sensitivity against platinum compounds, whereas pretreatment with N-acetyl-L-cysteine, which increase the intracellular GSH concentration, only marginally protected the cells from the cytotoxic effect of platinum compounds. The results suggest that platinum compounds-induced cytotoxicity can be modified by GSH-modulating compounds in glioblastoma and glioma cell lines.

Document emailed within 1 workday
Secure & encrypted payments